EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-ND 4.0

A characterization of patients with low soluble urokinase plasminogen activator receptor who died within 90 days of hospital discharge

Louise Westberg Strejby Christensen iD, Esben Iversen iD, Aino Leegaard Andersen, Anne Byriel Walls, Line Jee Hartmann Rasmussen, Ove Andersen, Thomas Kallemose, Morten Baltzer Houlind iD

Basic & Clinical Pharmacology & Toxicology · 2024

DOI: 10.1111/bcpt.14050 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Basic & Clinical Pharmacology & Toxicology, 2024. Verfasst von Louise Westberg Strejby Christensen und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Clinical Research, Copenhagen University Hospital Amager and Hvidovre, Hvidovre, Denmark. Hauptthemen laut MEDLINE: Receptors, Urokinase Plasminogen Activator, Patient Discharge, Biomarkers, Registries. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 39 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: Capital Regions Fund for Transitional Research, Danish Research Unit for Hospital Pharmacy, Amgros I/S, Copenhagen, Denmark, The Lundbeck Foundation.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Soluble urokinase plasminogen activator receptor (suPAR) is a marker of systemic chronic inflammation. Elevated suPAR levels are associated with adverse clinical outcomes, but a small subset of patients with low suPAR also experience poor outcomes. Therefore, we aimed to characterize patients presenting to the emergency department with low suPAR (

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Receptors, Urokinase Plasminogen ActivatorPatient DischargeBiomarkersRegistriesHumansMaleFemaleAgedMiddle AgedAged, 80 and overEmergency Service, HospitalPolypharmacyTime FactorsAge FactorsRisk FactorsCerebrovascular DisordersDementia

Stichwörter der Autor:innen

adverse clinical outcomesmedication reviewmortalitypolypharmacyrisk stratificationsuPAR

Substanzen

Receptors, Urokinase Plasminogen ActivatorBiomarkersPLAUR protein, human

Autor:innen und Institutionen

  • Department of Clinical Research, Copenhagen University Hospital Amager and Hvidovre, Hvidovre, Denmark.
  • The Capital Region Pharmacy, Herlev, Denmark.
  • Department of Drug Design and Pharmacology, University of Copenhagen, Copenhagen, Denmark.
  • Department of Clinical Medicine, University of Copenhagen, Copenhagen, Denmark.
  • Department of Psychology and Neuroscience, Duke University, Durham, North Carolina, USA.
  • Emergency Department, Copenhagen University Hospital Amager and Hvidovre, Hvidovre, Denmark.

ORCID-Profile: Louise Westberg Strejby Christensen, Esben Iversen, Morten Baltzer Houlind

Förderung

  • Capital Regions Fund for Transitional Research
  • Danish Research Unit for Hospital Pharmacy, Amgros I/S, Copenhagen, Denmark
  • The Lundbeck Foundation
  • Novo Nordisk Foundation
  • BRIDGE-Translational Excellence Program
  • Lundbeck Foundation
  • Novo Nordisk Fonden

Zitieren

APA

Christensen, L. W. S., Iversen, E., Andersen, A. L., Walls, A. B., Rasmussen, L. J. H., Andersen, O., Kallemose, T., & Houlind, M. B. (2024). A characterization of patients with low soluble urokinase plasminogen activator receptor who died within 90 days of hospital discharge. Basic & Clinical Pharmacology & Toxicology. https://doi.org/10.1111/bcpt.14050

Vancouver

Christensen LWS, Iversen E, Andersen AL, Walls AB, Rasmussen LJH, Andersen O, et al. A characterization of patients with low soluble urokinase plasminogen activator receptor who died within 90 days of hospital discharge. Basic & Clinical Pharmacology & Toxicology. 2024. doi:10.1111/bcpt.14050

BibTeX
@article{Christensen2024,
  author = {Christensen, Louise Westberg Strejby and Iversen, Esben and Andersen, Aino Leegaard and Walls, Anne Byriel and Rasmussen, Line Jee Hartmann and Andersen, Ove and Kallemose, Thomas and Houlind, Morten Baltzer},
  title = {A characterization of patients with low soluble urokinase plasminogen activator receptor who died within 90 days of hospital discharge},
  journal = {Basic & Clinical Pharmacology & Toxicology},
  year = {2024},
  doi = {10.1111/bcpt.14050}
}
Kostenlos starten →